NASDAQ:PRAX | Free Cash Flow | Praxis Precision Medicines, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$86.15M$62,000.00-$86.21M
2025-12-31-$76.33M$0.00-$76.33M
2025-03-31-$53.01M$0.00-$53.01M
2024-12-31-$56.12M$0.00-$56.12M
2024-03-31-$20.86M
2023-12-31-$23.86M$50,000.00-$23.91M
2023-03-31-$32.85M$0.00-$32.85M
2022-12-31-$28.81M$0.00-$28.81M
2022-03-31-$54.11M$289,000.00-$54.4M
2021-12-31-$44.86M$531,000.00-$45.39M
2021-03-31-$25.72M$4,000.00-$25.73M
2020-12-31-$20.23M$0.00-$20.23M
2020-03-31-$8.57M$0.00-$8.57M
2019-12-31-$9.95M$0.00-$9.95M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$249.07M$56,000.00-$249.12M
2024-12-31-$131.76M$0.00-$131.76M
2023-12-31-$111.14M$50,000.00-$111.19M
2022-12-31-$185.04M$444,000.00-$185.49M
2021-12-31-$124.55M$1.05M-$125.6M
2020-12-31-$52.62M$0.00-$52.62M
2019-12-31-$33.42M$103,000.00-$33.52M